Author:
Virgolini Irene,Traub-Weidinger T.
Reference277 articles.
1. Adamou A, Aiyar N, van Horn S, Elshourhagy NA (1996) Cloning and functional characterization of human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Commun 209:383–392
2. Ain KB, Taylor KD (1994) Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78:1097–1102
3. Ain KB, Taylor KD, Tofiq S, Venkataraman G (1997) Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines. J Clin Endocrinol Metab 82:1857–1862
4. Achilefu S, Srinivasan A, Schmidt MA, Jimenez HN, Bugaj JE, Erion JL (2003) Novel bioactive and stable neurotensin peptide analogue capable of delivering radiopharmaceuticals and molecular beacons to tumor. J Med Chem 46:3403–3411
5. Alexander RW, Upp Jr JR, Poston GJ, Gupta V, Townsend Jr CM, Thompson JC (1988) Effects of bombesin on human small cell carcinoma in vivo. Cancer Res 48:1439–1441